Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
about
The renal effects of SGLT2 inhibitors and a mini-review of the literature.Diabetes drugs and the incidence of solid cancers: a survey of the current evidence.SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus.SGLT2 Inhibitors: Benefit/Risk Balance.SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.The impact of insulin resistance on the kidney and vasculature.Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report.ISN Forefronts Symposium 2015: Maintaining Balance Under Pressure-Hypertension and the Proximal Tubule.A more tubulocentric view of diabetic kidney disease.Multi-scale mathematical model of drug-induced proximal tubule injury: Linking urinary biomarkers to epithelial cell injury and renal dysfunction.Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function.Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study
P2860
Q37632127-3C7B8902-28C5-47BC-9B85-78702BF07828Q38651175-4B7CF5DE-1DB2-4528-AB0E-3DFBA6FE24B4Q38775305-AF39EB21-D763-42F2-898B-70417D746F5CQ38783130-A44385A1-6E02-4770-BE21-D51639D842D6Q38931842-4EC0BF1D-94F9-4DD2-9001-57F14275A372Q38961637-297CF861-0F93-4195-BC2B-9242CDCB3B02Q38982413-C05C4E91-0199-43BB-A508-6860B4C6F449Q39170860-1B6BC4BF-C7A6-4A63-BC6D-FB0AE261DD11Q42002820-3F313C3A-065F-4633-9954-40DA0B84B91EQ42080888-99D94DDD-6152-4DF4-B97C-8EE043AE5617Q47108081-192587D0-B0E4-4B07-8D4B-C7710A2AEEAFQ47360743-EAD882D4-6402-415A-A444-2822EE5476C7Q48698019-BF6E7B8D-CEE4-45DD-B482-E154E2F36EC7Q52889769-B917A73D-DF44-458F-866F-362B34F22F69Q57136996-3FDE33DD-A441-4CE7-BB58-13ECA1CB6185
P2860
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@ast
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@en
type
label
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@ast
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@en
prefLabel
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@ast
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@en
P2860
P1476
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
@en
P2093
Aleksandra Novikov
P2860
P356
10.1097/MNH.0000000000000187
P577
2016-01-01T00:00:00Z